Login / Signup

Clinical Course of Partial Virologic Response with Prolonged Tenofovir Therapy in Nuclos(t)ides-Naïve Patients with Chronic Hepatitis B.

In Du JeongSeok Won JungBo Ryung ParkByung Uk LeeJae Ho ParkByung Gyu KimSung-Jo BangJung Woo ShinNeung-Hwa Park
Published in: Digestive diseases and sciences (2017)
The vast majority of CHB patients with PVR achieved VR through prolonged TDF therapy, although the time to achieve VR was delayed in those with PVR. This suggests that adjustment of TDF therapy in patients with PVR is unnecessary.
Keyphrases
  • hepatitis b virus
  • antiretroviral therapy
  • virtual reality
  • hiv infected
  • cell therapy
  • bone marrow
  • smoking cessation